Solon Ventures

Fever is a live-entertainment discovery platform that enables individuals to explore unique local experiences and events in their cities, such as immersive art exhibitions, interactive theater, festivals, and classical music concerts. The platform aims to democratize access to culture and entertainment by providing personalized and curated lists of events tailored to user preferences across various locations. Through its services, Fever simplifies the process of booking events and accessing popular attractions, while also empowering creators with data and technology to develop and enhance their offerings.

Prosonix Ltd. is a specialty pharmaceutical company based in Oxford, United Kingdom, focused on developing and marketing inhaled medicines for the treatment of asthma and chronic obstructive pulmonary disease. Established in 2006, the company specializes in creating generic mono and combination therapies that incorporate inhaled corticosteroids, long-acting beta agonists, and long-acting muscarinic antagonists. Prosonix employs proprietary ultrasonic particle engineering technologies to enhance the manufacture of inhaled medications, enabling the design of drug particles tailored for effective inhalation. The company also works on dual and triple combination therapies to provide comprehensive treatment options for respiratory conditions. As of mid-2015, Prosonix operates as a subsidiary of Circassia Limited.

Xceleron, founded in 1997 in York, UK, and now based in Germantown, Maryland, specializes in bioanalytical accelerator mass spectrometry (AMS) services to enhance drug development. The company pioneered techniques for human microdosing and microtracing, focusing on the pharmacokinetics and metabolism of developmental drugs during early clinical trial phases. Xceleron's services include micro-dosing, preclinical evaluation, intravenous pharmacokinetics, metabolite profiling, and mass balance investigations in humans. Their expertise is particularly valuable given the complexity of modern small molecules, which often exhibit low solubility and lengthy half-lives, necessitating early pharmacokinetic characterization to improve the cost-effectiveness of clinical development. Through a commitment to integrity and collaboration, Xceleron aims to accelerate the delivery of life-changing products to the market.

Prosonix Ltd. is a specialty pharmaceutical company based in Oxford, United Kingdom, focused on developing and marketing inhaled medicines for the treatment of asthma and chronic obstructive pulmonary disease. Established in 2006, the company specializes in creating generic mono and combination therapies that incorporate inhaled corticosteroids, long-acting beta agonists, and long-acting muscarinic antagonists. Prosonix employs proprietary ultrasonic particle engineering technologies to enhance the manufacture of inhaled medications, enabling the design of drug particles tailored for effective inhalation. The company also works on dual and triple combination therapies to provide comprehensive treatment options for respiratory conditions. As of mid-2015, Prosonix operates as a subsidiary of Circassia Limited.

Mobcast was founded in 2007 by CEO Tony Lynch and bestselling author Andy McNab. With the rise in the capabilities of mobile phones they spotted an opportunity to develop an online retail platform for digital books on these devices. They recognised the potential of gaining access to large customer bases and billing infrastructures through partnerships with mobile network operators, equipment manufacturers and retailers.

Concentra Analytics was formed in 2008 to bring data science to management practice in a sustainable way. Concentra Analytics builds Software as a Service ("SaaS") data solutions that enable businesses to capture, manage and use data to analyse and transform their operations. A two-time winner at the Corporate Vision Technology Innovator Awards, in 2016 it was named the 'Most Innovative Business Analytics Company' and its flagship product, OrgVue, was awarded 'Best Strategic HR Product' as well as voted a 'Gartner Cool Vendor in Human Capital Management'. Alongside OrgVue, Concentra's other products include SupplyVue for holistic supply chain optimisation and DataPlus, an enterprise data warehouse automation platform. Concentra's analytics and domain experts also leverage best-in-class technologies to build data-driven solutions in functional operational reporting and customer analytics.

Nimbus makes life at work easier, faster and more valuable for millions of people. Since its inception in 1997, Nimbus has helped over 700 organizations - including: Astrazeneca, Barclays Capital, HSBC, JPMorgan, RBS, Sara Lee, Toyota, and ThyssenKrupp.

Gaming Technology Solutions (GTS) is a global provider of gaming solutions focused on online gaming operations, established in 2005. The company specializes in delivering games through its open EdGE platform, which allows for cross-channel gaming experiences. GTS is licensed by the UK government to ensure compliance with legal regulations and exclusively offers its services to licensed gaming operators that accept bets from legitimate jurisdictions. Since its acquisition by Playtech in 2009, GTS has expanded its reach, now supplying open gaming services to over 90 internet operators worldwide.

Peakdale Molecular is a contract research organization. It provides drug discovery services to the pharmaceutical, biotech, diagnostics, and materials sciences industries. They operate a comprehensive suite of services for hit-to-lead and lead optimization studies, including early stage ADME. It offers a variety of customized commercial frameworks, from simple fee-for-service to long-term FTE projects. The company provides services such as drug discovery support, nucleoside chemistry, materials chemistry, research support, and business models. Peakdale Molecular was founded in 1992 and is headquartered in High Peak, Derbyshire.

Novalia Limited is an innovative technology company based in Cambridge, United Kingdom, specializing in the development of paper-thin self-adhesive touch sensors created from printed conductive ink and silicon microcontroller modules. Founded in 2006, Novalia focuses on designing and manufacturing bespoke interactive solutions that enhance the connection between brands and their audiences. By combining conductive printing with capacitive touch technology, the company produces smart surfaces that can serve as both sensors and speakers, facilitating wireless communication between the digital and physical worlds. Novalia's applications span various sectors, including media, advertising, music, healthcare, and direct marketing, allowing brands to engage their target audiences in novel and interactive ways.